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Most models for predicting malignant pancreatic intraductal papillary mucinous neoplasms were 
developed based on logistic regression (LR) analysis. Our study aimed to develop risk prediction 
models using machine learning (ML) and LR techniques and compare their performances. This was 
a multinational, multi‑institutional, retrospective study. Clinical variables including age, sex, main 
duct diameter, cyst size, mural nodule, and tumour location were factors considered for model 
development (MD). After the division into a MD set and a test set (2:1), the best ML and LR models 
were developed by training with the MD set using a tenfold cross validation. The test area under the 
receiver operating curves (AUCs) of the two models were calculated using an independent test set. A 
total of 3,708 patients were included. The stacked ensemble algorithm in the ML model and variable 
combinations containing all variables in the LR model were the most chosen during 200 repetitions. 
After 200 repetitions, the mean AUCs of the ML and LR models were comparable (0.725 vs. 0.725). The 
performances of the ML and LR models were comparable. The LR model was more practical than ML 
counterpart, because of its convenience in clinical use and simple interpretability.
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Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are premalignant lesions. The 2017 interna-
tional consensus guidelines (ICG) on IPMNs proposed three high-risk stigmata and seven worrisome features as 
potential risk factors for malignant  IPMNs1. Soon after, Kang et al. evaluated the hazard ratio (HR) of each risk 
factor listed in the ICG and demonstrated that the statistical significance differed among these factors because 
each risk factor had a different HR (3–9)2. Patients with IPMN routinely present with multiple different risk 
features of different degrees. Since then, models that can quantitatively predict malignancy have been deemed 
desirable.
Recently, several nomograms for quantitatively predicting malignant IPMNs were  published3–5. The process 
of building these nomograms was mainly based on multivariate logistic regression (LR) analysis. These LR-based 
nomograms showed moderate prognostic predictability in the external validation with the area under the receiv-
ing operator curves (AUCs) ranging from 0.74 to 0.83.
Machine learning (ML) is a computational method that can establish ideal models for classification, predic-
tion, and estimation by ‘automatically’ learning from a large-scale complex input and output  dataset6. Recently, 
ML techniques have been utilized in a variety of medical fields, especially for diagnosing anticipated histopathol-
ogy from radiologic  images7,8, predicting disease  prognosis9, and establishing models for differentiating benign 
and malignant diseases. For example, one study reported that a deep-learning-based model can detect early breast 
cancer from observed patterns of micro-calcifications in mammography with an accuracy of more than 85%10. 
Thus far, few studies have used ML techniques for predicting pancreatic malignancy. Therefore, the present study 
aimed to develop ML technique-based models for predicting malignant IPMNs using a multinational multi-
institutional dataset and compare the diagnostic predictabilities of ML and LR techniques.
Results
Patient demographics and prognostic factors for malignant IPMNs in the multivariate LR 
analysis. A total of 3,708 patients, with a mean age of 65.4 years and a 1:4 male to female ratio, who had 
both clinical and radiological data were included in our study (see Table 1). This cohort included benign and 
malignant IPMN. The majority of pancreatic cysts in this cohort were located at the head (59.5%), followed by 
the body or tail (34.1%); 6.4% were diffuse type IPMNs with lesions in multiple locations. The mean cyst size was 
30.3 mm, mean MPD diameter was 4.8 mm, and mural nodules were present in 1,285 patients (37.1%). In the 
multivariate LR analysis, age (OR 1.02, 95% CI 1.01–1.03, P < 0.001), sex (OR 1.22, 95% CI 1.05–1.42, P = 0.010), 
cyst size (OR 1.02, 95% CI 1.01–1.02, P < 0.001), MPD diameter (OR 1.24, 95% CI 1.20–1.28, P < 0.001), and 
presence of mural nodules (OR 2.38, 95% CI 2.05–2.78, P < 0.001) were independent risk factors for malignant 
IPMNs. Compared to the head lesions, body or tail lesions were significantly less malignant (OR 0.74, 95% CI 
0.62–0.87, P < 0.001), and diffuse type lesions were more malignant (OR 1.54, 95% CI 1.14–2.08, P = 0.005).
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Selection of the best ML algorithm after tenfold CV. During 200 repetitions, we counted the number 
of ML algorithms that ranked first after the tenfold CV in each seed (see Fig. 1). SE was the most selected algo-
rithm (n = 132), followed by GLM (n = 47), GBM (n = 11), and XG boost (n = 10). In addition, we calculated the 
highest tenfold CV AUC among each Auto ML algorithm in each random seed and evaluated the mean tenfold 
CV AUC for comparing the performance of each Auto ML algorithm. The SE algorithm had the highest mean 
AUC, followed by GLM, XG Boost, GBM, and DL (see Fig. 2).
Comparison of the performances between ML and LR models. Figure 3 shows the performances of 
AutoML and LR models after 200 repetitions. Overall, the mean AUC of both the models was 0.725.
Discussion
It has been established previously that each risk factor proposed in the 2017 ICG has different  HRs1,2, hence mod-
els for predicting IPMN malignancy would need to be quantitative to accurately establish treatment strategies. LR 
has been widely used because of its simple structure and interpretability of coefficients. Several quantitative nom-
ograms were developed with their own beta coefficient of risk factors based on the multivariate LR  analysis3–5. 
For example, users can calculate and obtain the probability of malignant IPMNs easily and immediately, using a 
nomogram available at https ://statg en.snu.ac.kr/softw are/nomog ramIP MN. However, these nomograms showed 
similar moderate performances, in that, the AUCs did not exceed 0.85. In the current study, the LR model was 
Table 1.  Predictive factors for malignant intraductal papillary mucinous neoplasm in the univariate and 
multivariate logistic regression analysis. IPMN, intraductal papillary mucinous neoplasm; MPD, main 
pancreatic duct.
Total (N = 3,463)




(N = 1369) P value Odds ratio 95% CI P value
Age (mean ± SD, year) 65.4 ± 9.9 64.5 ± 9.8 66.7 ± 10.0  < 0.001 1.02 1.01 – 1.03  < 0.001
Sex (No.) 0.195
Female 1,266 (36.6%) 784 (37.4%) 482 (35.2%) Ref Ref
Male 2,197 (63.4%) 1,310 (62.6%) 887 (64.8%) 1.22 1.05 – 1.42 0.010
Location (No.)  < 0.001
Head 2,059 (59.5%) 1,175 (56.1%) 884 (64.6%) Ref Ref
Body or tail 1,180 (34.1%) 818 (39.1%) 362 (26.4%) 0.74 0.62 – 0.87  < 0.001
Diffuse 224 (6.4%) 101 (4.8%) 123 (9.0%) 1.54 1.14 – 2.08 0.005
Cyst Size (mean ± SD, 
mm) 30.3 ± 16.3 28.6 ± 14.5 33.6 ± 18.2  < 0.001 1.02 1.01 – 1.02  < 0.001
MPD diameter 
(mean ± SD, mm) 4.8 ± 2.5 4.2 ± 2.3 5.6 ± 2.5  < 0.001 1.24 1.20 – 1.28  < 0.001
Mural nodule (No.) 1,285 (37.1%) 576 (27.5%) 709 (51.8%)  < 0.001 2.38 2.05 – 2.78  < 0.001
Figure 1.  The number of the first ranked machine learning algorithm chosen in the tenfold cross validation 
during 200 times repetition.
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established with several risk factors based on the multivariate LR analysis (see Table 1). To reduce the selection 
bias derived from random splits, these processes were repeated 200 times (see Fig. 4). The overall performance 
of the LR models was 0.725 (see Fig. 3), slightly lower than previous studies (0.72–0.85)3,5,11. To increase the 
performance, we hypothesized that prediction models based on different statistical techniques, such as the ML 
technique, can be potentially used as an alternative method for prediction and  classification12.
ML algorithms have been utilised in a variety of medical applications in the twenty-first century. Due to faster 
data processing and improved computer functions, large number of data are processed in a short time leading 
to rapid advances in machine learning. ML algorithms can provide supportive information or additional aids 
for improving the accuracy and efficiency of diagnosis and  treatment13, or aid in developing models to predict 
the  prognosis14. The performance of models using ML algorithms is considered acceptable and comparable to 
human  performance15. To evaluate the performance of ML in this study, LR was chosen as a baseline comparison.
The incidence of patients with pancreatic disease is quite rare; hence, it is difficult to apply ML algorithms 
for developing and validating the models in one institutional unit. Our study included over 3,708 patients from 
Figure 2.  The mean highest tenfold cross validation are under the receiver operating curves of each algorithm 
during 200 times repetition. AUC indicates area under the receiver operative curve.
Figure 3.  The overall performance of machine learning (ML) and logistic regression (LR). The performance 
of optimal ML model (Auto ML) was comparable with that of LR model (mean AUC, 0.725 vs. 0.725). AUC 
indicates area under the receiver operating curve.
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31 institutions across 8 countries; therefore, the entire cohort consisted of a wide variety of ethnic groups across 
varied environments and health care systems.
Overfitting is one of the problems of a statistical model over-trained with the internal dataset, demonstrat-
ing unreliable performance and low diagnostic predictability when applied in the real  world16. In our study, to 
overcome the overfitting problem and demonstrate real performance, the total dataset was divided into the MD 
and test set, and the model development and validation was performed on the two independent datasets (see 
Figure 4.  Overall flowchart of whole process. The workflows of both logistic regression (LR) and machine 
learning (ML) were separately processed in the same model development (MD) set. The whole process was 
repeated 200 times for reducing the selection bias which occurred during random split with test set and MD set. 
MD, model development; LR, logistic regression; Auto ML, automated machine learning; AUC, area under the 
receiver operating curve.
Figure 5.  The process of calculation of test area under the receiver operating curves (AUCs) during 200 times 
repetition. After tenfold cross validation and selection of the first rank automated machine learning (Auto ML) 
model structure, this Auto ML model structure was fit with the model development set at each seed and the best 
ML model developed. Then the AUC was calculated with the test set. This process was repeated 200 times and 
mean AUC was calculated and compared.
6
Vol:.(1234567890)
Scientific Reports |        (2020) 10:20140  | https://doi.org/10.1038/s41598-020-76974-7
www.nature.com/scientificreports/
Fig. 4). In addition, to reduce the selection bias during one random split, 200 repetitions were performed, and 
the mean test AUC was calculated (see Fig. 5); this reflected a reliable and accurate performance of ML and LR 
techniques in real practice.
The advantage of the ‘AutoML’ package program is that it automatically searches for the best ML algorithm 
and the best model for the particular structured data. After 200 repetitions, the mean test AUCs were compa-
rable between the ML and LR models (0.725 vs. 0.725, see Fig. 3). In other words, both statistical techniques 
demonstrated the same performance in terms of developing models for the prediction of malignant IPMNs. 
Furthermore, we calculated the performance of each ML algorithm and counted the number of first-ranked ML 
model structures in each tenfold CV. Considering that the SE is an ensemble technique, the GLM had the highest 
mean tenfold CV AUC (see Fig. 1) among the independent AutoML algorithms, and it was selected more than 
the GBM, XG Boost, or DRF (see Fig. 2). In contrast with the GBM, XG Boost, and DRF, which were decision 
tree-based algorithms and fitted well with nonlinear  association17,18, GLM and LR were based on linear regression 
analysis. These results indicated that the selected variables had a linear relationship with predicting malignant 
IPMNs, and the AutoML package program selected the algorithm that reflected the linear relationship as the 
best algorithm. If the variables with nonlinear relationships were involved in model development, the optimal 
ML algorithm might be changed.
Researchers developed ML models in a variety of medical fields and compared the performances of conven-
tional LR and ML techniques. Some studies reported that ML models had more accurate predictability than LR 
 models19–22, while others reported that ML and LR models had comparable  predictability23,24. One study per-
formed a systemic review and claimed that the performance of ML models was higher than that of LR models 
when ML models had a high risk of bias, and that the performances of ML and LR models were comparable 
when ML models had a low risk of  bias12. Therefore, a more meticulous and accurate methodological approach 
is needed when conducting research using  ML12. ML is not a replacement, but a complement, to LR. Therefore, 
the optimal statistical method can differ depending on the nature of the data or the purpose of the prediction 
problem.
Although the number of datasets were not sufficient to take advantage of ML, our study is the first to evaluate 
and compare the performances of ML models to LR in predicting pancreatic malignancy. The six variables had 
a relatively simple structure. Recently, ML techniques have been utilised to develop disease prediction models 
with high-dimensional omics data, such as the genomics and transcriptomics data, and these approaches out-
performed existing prediction  methods25,26. If the genomics or transcriptomics data on IPMN can be included 
in the future model development with ML techniques, the performance may be increased.
This study had some limitations. Because this study only enrolled the patients who underwent surgical 
resection due to IPMN, the results of this study did not represent the diagnostic performance in the general 
population in daily clinical practice. However, this study focused on the comparisons of diagnostic performance 
of two statistical methods, LR and ML. Although this was a retrospective cohort study with limited number of 
variables, the enrolled cohorts were multi-institutional and multinational. To prospectively enrol a large number 
of IPMN patients with standardised variables in a well-established collaborative study group would be desirable 
for future studies.
In summary, the performances of ML and LR models for predicting malignant IPMNs were comparable. The 
LR model would be more practical in clinical circumstances because of its simple interpretability and conveni-
ence in clinical use.
Materials and methods
Patients. The participating institutions in our retrospective cohort study with a multinational, multi-institu-
tional medical database included 9 from Korea, 13 from Japan, 2 from China, 2 from Taiwan, 2 from the United 
States, 1 from the Netherlands, 1 from Sweden, and 1 from Italy. Patients who underwent a curative-intent surgi-
cal resection and had pathologic confirmation of IPMN between 1992 and 2017 were enrolled. Of all cohorts, 
patients who had both clinical characteristics (age and sex) and radiological characteristics (tumour location, 
cyst size, main pancreatic duct (MPD) diameter, and the presence of mural nodules) were included in our study. 
Tumour markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9, were excluded during the 
analysis because they were not routinely evaluated preoperatively in the United States and Europe. According to 
the 2015 World Health Organization criteria, IPMN is graded as benign for a low-grade dysplasia and malignant 
for a high-grade dysplasia or an associated invasive  carcinoma27. None of the cohorts had missing values.
Our study was approved by the institutional review board (IRB No. 1912-050-108) at Seoul National Uni-
versity Hospital, and the informed consents were obtained from all subjects. All methods were carried out in 
accordance with relevant guidelines and regulations.
Preoperative radiologic evaluation. Preoperative radiologic parameters were evaluated with multi-
detector computed tomography (CT) using either Brilliance 64 (Philips Medical Systems, Cleveland, OH, USA) 
or LightSpeed Ultra (GE Healthcare, Little Chalfont, UK), or magnetic resonance imaging (MRI) using Mag-
netom Verio (Siemens Healthcare, Erlangen, Germany). The tumour location was categorised as the head, body, 
tail, and diffuse. The cyst size, MPD diameter, and mural nodules were mainly measured from cross-sectional 
CT or MRI images and by using endoscopic ultrasonography (EUS) as required. All detectable mural nodules 
were recorded regardless of their size. Patients with MPD diameters greater than 10 mm in size were excluded 
from our study, as the definite main-duct type IPMN was not considered.
ML model structure generation. We utilised ‘Automated machine learning (AutoML)’ in the H2O pack-
age from R program ver. 3.3.3 (R Foundation for Statistical Computing, Vienna, Austria) to automatically gen-
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erate ML model structures based on seven ML algorithms: XG Boost, deep learning (DL), distributed random 
forest (DRF), generalised linear model (GLM), gradient boosting machine (GBM), extremely randomized trees, 
and stacked ensemble (SE). SE is an ensemble method that makes final predictions by incorporating decisions 
made from different models trained from other  algorithms28.
For the attributes, for LR model we used logit link function and iteratively reweighted least squares (IWLS) 
estimation which is the default algorithm in glm() function in stats v3.6.2 package. Likewise, for ML model we 
used default options for automl() function in H2O v3.3.0 package.
Development and evaluation of ML and LR models. The overall workflows are depicted in Fig. 4. To 
perform the model development and validation independently, the cohort was randomly divided into a model 
development (MD) set and a test set (2:1) in each random seed. For the LR model, we calculated the tenfold CV 
AUC for all possible LR models fitted with each variable set from all possible combinations. The one with the 
highest CV AUC was selected as the best variable combination.
For the ML model, the complete dataset of all collected variables was utilised because Auto ML applied many 
different ML algorithms to find the best model for the given training data. The tenfold CV was performed to 
evaluate the performance of all Auto ML model structures generated by the H2O package, and the one with the 
highest tenfold CV AUC was selected. A similar approach was used to predict an acute kidney injury after liver 
transplantation using clinical  variables22.
Thereafter, the MD set was applied to both the LR and AutoML models to determine the best LR and AutoML 
model, respectively. Finally, the performances of these two models were evaluated with the test set to calculate 
their test AUCs.
To reduce selection bias, the entire process of the MD and test set division, the best LR and ML model selec-
tion, and test AUCs calculation was repeated 200 times. Figure 5 shows the process of calculation of the test 
AUCs during the whole random seed (1–200) with the ML model. Similar repetitions and calculations were 
performed with the LR model. To compare the overall performances of the LR and ML techniques, mean test 
AUCs were evaluated and compared.
Statistical analysis. Categorical variables were compared using the chi-square test. Continuous variables 
were compared using the Student t-test. Variables with P < 0.05 in the univariate analysis were entered into a 
multivariate LR model to find significant predictors and estimate the odds ratios (ORs) for the corresponding 
predictors. Data was considered statistically significant when P < 0.05 in 2-tailed tests. All statistical analyses 
were performed using IBM SPSS Statistics ver. 22.0 (IBM Co., Armonk, NY, USA) and R program ver. 3.3.3.
Data availability
The datasets generated during the current study are not publicly available due to our institutional review board 
prohibits publication of patient’s personal medical records.
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